SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.

Otros idiomas Shandong Sinobioway Biomedicine Co., Ltd.

Acciones

002581

CNE1000012Y5

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
13,35 ^CNY	-2,48 %		-3,26 %	-8,56 %

29/04	Shandong Sinobioway Biomedicina Co. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
29/04	Shandong Sinobioway Biomedicina Co. Ltd., presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Sinobioway Biomedicine's Unit to Relocate	12/12
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Shandong Sinobioway Biomedicine Co., Ltd.(XSEC:002581) added to S&P Global BMI Index	18/09/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Sinobioway Biomedicine Taps Builders for Planned Industrial Park	17/08/23
Sinobioway Biomedicine Earmarks 1 Billion Yuan for Pharmaceutical Industrial Park	27/04/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Shandong Sinobioway Biomedicine Co., Ltd. Announces Executive Appointments	23/08/22
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.	02/06/22
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21
Xiamen Hengxing Group Co., Ltd. acquired Shandong Sinobioway Biomedicine Co., Ltd. from Shenzhen Sandao Investment Management Enterprise (Limited Partnership) for CNY 200 million.	18/09/21
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/08/21
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	26/10/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Shandong Sinobioway Biomedicine Co., Ltd.

Acciones

002581

CNE1000012Y5

Otros idiomas

Filtros